Schedule 13G ownership disclosure

F-STAR THERAPEUTICS INC

Security class unavailable · CUSIP: 30315R107

Event date: 2020-11-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
803,922
Percent of class
8.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-20-010374
Form type
SC 13G
Filer
F-star Therapeutics, Inc.
CIK
CIK 1566373
Filed
Nov 30, 2020
Reporting period
Nov 20, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub